Skip to main content
OpenTrials

Clinical trial condition

Metastatic Colorectal Carcinoma

Explore clinical trials studying Metastatic Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.

38 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Colorectal Carcinoma trial results

Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

NCT05322590

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Irvine Health Orange, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Hospitals and Clinics Miami, Florida, United States
View Trial Details
Active, Not Recruiting

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

NCT04294264

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
Locations
  • Trinitas Hospital and Comprehensive Cancer Center Elizabeth, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
  • Saint Barnabas Medical Center Livingston, New Jersey, United States
  • RWJBarnabas Health - Monmouth Medical Center Long Branch, New Jersey, United States
View Trial Details

Related conditions